Beyond Meat BYND 深 滬
等待開盤 10-02 09:30:00 美东时间
2.31
+0.420
+22.22%
華盛通- 最 高2.43
- 今 開1.965
- 成交量 2072.32万股
- 最 低 1.95
- 昨 收 1.89
- 總市值 1.77亿
- 52周最高 6.81
- 市盈率 靜 --
- 換手率 27.10%
- 52周最低 1.23
- 委 比 -4.37%
- 總股本 7647.14万
- 歷史最高 239.71
- 量 比 1.22
- 振 幅 25.40%
- 歷史最低 1.23
- 每 手 1
- 風險率 1.04%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅超31%！摩根大通维持通用汽车"超配"评级，目标价从60美元升至80美元
今日重点评级关注：Maxim Group：上调Adial Pharmaceuticals评级至"买入"，目标价1.5美元；BTIG：维持Climb Bio"买入"评级，目标价从7美元升至8美元
10-01 20:13
盘前异动丨Wolfspeed暴涨50%，回声星通信涨逾6%，热门中概股走高
9月30日周二，美股三大指数期货在盘前时段小幅走低。今日关注：美国9月芝加哥PMI、JOLTs职位空缺、谘商会消费者信心指数等重要数据。 Wolfsp...
09-30 16:12
期权扫描 | Robinhood股价创新高，一看涨期权飙升1075%；Tilray期权成交放量1457%
Robinhood股价创新高，一看涨期权飙升1075%；大麻股迎利好！Tilray期权成交放量1457%，看涨期权占近90%>>
09-30 10:47
Beyond Meat Launches Major Debt Exchange Initiative
Beyond Meat ( ($BYND) ) has issued an announcement. On September 29, 2025, Beyo...
09-29 20:50
Beyond Meat Launches Exchange Offer and Consent Solicitation Intended to Eliminate Over $800 Million of Debt with Existing Noteholder Support
Beyond Meat announces an exchange offer to convert its 0% Convertible Senior Notes due 2027 into new 7.00% Convertible Senior Secured Second Lien PIK Toggle Notes due 2030 and common stock, aiming to reduce leverage and extend maturity. The offering also includes a consent solicitation to amend restrictive covenants in the notes' indenture. Approximately 47% of existing noteholders have agreed to support the offer, subject to certain conditions.
09-29 12:15
Beyond Meat Wins Arbitration Against Co-Manufacturer
The latest announcement is out from Beyond Meat ( ($BYND) ). Beyond Meat, Inc. ...
09-19 04:51
AI 成为美股投资最大主题：“这不是 ROI 问题，是生存问题”
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 来源：晚点LatePost “大家都想寻找新故事，但最多的资金还...
09-17 19:14
Argus Research Downgrades Beyond Meat to Sell
Argus Research analyst John Staszak downgrades Beyond Meat (NASDAQ:BYND) from Hold to Sell.
09-15 22:12
FDA starts daily publication of adverse event data
The U.S. Food and Drug Administration said that it has begun the daily publication of adverse event reports related to drugs and biological products. This marks a shift from the previous quarterly upd...
08-23 04:05
